Should I start this new med if I might have liver impairment?

[Layla_D]

I’ve been prescribed a new medication and the information sheet lists “hepatic impairment” as a major precaution. My doctor mentioned my slightly elevated liver enzymes from last year’s bloodwork in passing, but didn’t explicitly say I have that condition. I’m unsure if I should start the pills or call back to clarify—how do you even define when regular test results cross into actual impairment?

[Noah.J]

That phrase can feel heavier than it is. Hepatic impairment is a clinical label for compromised liver function, not a single lab value. Doctors often want to see persistent or rising elevations across several tests—ALT, AST, ALP, bilirubin—plus symptoms or imaging before calling it impairment. A one time, mild bump last year doesn’t automatically mean you have it, but it’s reasonable to ask for clarity before starting a med with that precaution.

[TimothyGL]

I did a baseline LFT before starting and asked for a clear follow‑up plan. The first recheck came in a few weeks, then every few months; nothing dramatic showed up, but I stayed in touch with my doctor.

[Dennis.L]

Do you actually have liver disease, or was it just a mild, lingering enzyme bump?

[Samuel_A]

I ended up calling the clinic to get exact thresholds and whether the med should be started right away. They explained what counts as abnormal in practice and what would trigger stopping or switching. It helped me feel a little steadier, even if I’m still not sure.